. Characterization of hemozoin and binding to CLEC12A reporter cells. Related to Figure 1 
. (A)
Scanning electron microscopy of synthetic hemozoin. Synthetic hemozoin was sputtered with gold and visualized using a scanning electron microscope. Data are representative of two independent experiments (n=2). Bar represents 1 µm. (B) Reporter cell assay with parasitized RBCs (pRBCs). Recognition of MSU (250µg/ml), hemozoin (100µg/ml), lysates of pRBCs (ratio 20:1) and lysates of uninfected RBCs (uRBCs, ratio 20:1) by a hCLEC12A-CD3 reporter cell line. A murine CLEC7A-CD3 reporter cell line served as negative control. Data are presented as mean + SD and representative of three independent experiments (n=3) in triplicates. Statistical significance was evaluated using unpaired, two-tailed Student's t-test. Asterisks indicate significant differences (***p<0.001, ****p<0.0001). + T cells after hemozoin stimulation. Cells were stained for CD69 and analyzed by flow cytometry. Graph shows one out of two experiments (n=2) in triplicates and displayed as mean + SD. Statistical significance was evaluated using unpaired, two-tailed Student's t-test. Asterisks indicate significant differences (*p<0.05, **p<0.01, ****p<0.0001) -/-: n=9, 5, 5; total n=19 mice). Due to the development of ECM symptoms, mice had to be euthanized according to defined humane endpoints. Thus, the number of mice (particularly C57BL/6 mice) included in the parasitemia detection decreased during the course of PbA infection. Line represents means. No significant differences were observed between PbA-infected WT and CLEC12A -/-mice. (B) Levels of proinflammatory cytokines in CLEC12A -/-mice infected with PbA. Mice were infected with PbA and serum samples were obtained on day 6 post infection. Samples were analyzed by cytometric bead array using beads capturing soluble TNF-α, IL-1ß, IL-4, IL-6, IL-12/IL-23 p40, and IFN-γ. Depicted are systemic levels of TNF-α, IFN-γ, and IL-6. Remaining cytokines were below the detection limit. Data are expressed as mean + SEM and are representative of two independent experiments (n=5 mice). Statistical analysis was performed using unpaired, one-tailed t-test. Asterisks indicate significant differences (*p<0.05, **p<0.01), n.s.=not significant. (C) Leukocyte sequestration in brains of CLEC12A -/-mice. CLEC12A -/-and WT control mice were challenged with PbA and sacrificed on day 6 post infection. Brains were dissected and homogenized to release intravascular leukocytes. Sequestered cells were stained using antibodies directed against CD45, CD8, CD62L, and analyzed by flow cytometry. Brains from uninfected mice were used as control. Statistical analysis for brain-sequestered CD45 + leukocytes and activated CD8 + T cell numbers. Data are expressed as mean + SEM and representative of two independent experiments (n=5 mice). Statistical analysis was performed using unpaired, two-tailed t-test. Asterisks indicate significant differences (*p<0.05, ***p<0.001). n.s. = not significant. (D) Genotyping of CLEC12A -/-mice. DNA isolated from WT (+/+) and homozygous CLEC12A knockout mice (-/-) was analyzed by PCR. Arrows indicate target bands for each genotype and corresponding amplicon sizes. Absence of CLEC12A expression was further confirmed by CLEC12A surface staining of leukocytes followed by flow cytometric analysis. Illustrated are overlay histograms of bone marrow cells and splenocytes derived from CLEC12A +/+ or CLEC12A -/-mice. (E) Model for the role of CLEC12A in ECM pathogenesis. Rupture of parasitized RBCs causes the release of hemozoin and merozoites. Hemozoin is recognized by CLEC12A expressed by dendritic cells (DCs), thereby elevating reactive oxygen species (ROS) production. In addition, uric acid crystals or other endogenous ligands released from damaged cells may be recognized by CLEC12A. In parallel, Plasmodium antigens are recognized by DCs, resulting in uptake and cross-presentation of antigens to CD8 + T cells. Elevated ROS levels may contribute to altered CD8 + T cell activation, leading to increased frequencies of granzyme B (GrB)-expressing CD8 + T cells in the spleen. Primed GrB-positive CD8 + T cells migrate to the blood brain barrier (BBB) and release inflammatory mediators, particularly GrB, thereby causing an impairment of the BBB. Consequently, a high number of GrB-expressing CD8 + T cells is found in the brain, leading to the development of experimental cerebral malaria (ECM).
